CN103396496A - 一种改性嗜酸乳杆菌肽聚糖的制备方法 - Google Patents
一种改性嗜酸乳杆菌肽聚糖的制备方法 Download PDFInfo
- Publication number
- CN103396496A CN103396496A CN2013103017527A CN201310301752A CN103396496A CN 103396496 A CN103396496 A CN 103396496A CN 2013103017527 A CN2013103017527 A CN 2013103017527A CN 201310301752 A CN201310301752 A CN 201310301752A CN 103396496 A CN103396496 A CN 103396496A
- Authority
- CN
- China
- Prior art keywords
- peptidoglycan
- enzyme solution
- water
- lactobacterium acidophilum
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 title claims abstract description 69
- 108010013639 Peptidoglycan Proteins 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 240000001046 Lactobacillus acidophilus Species 0.000 title abstract 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 title abstract 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 title abstract 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 52
- 102000004190 Enzymes Human genes 0.000 claims abstract description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims abstract description 16
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims abstract description 15
- 238000005238 degreasing Methods 0.000 claims abstract description 9
- 239000012535 impurity Substances 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims description 41
- 238000012986 modification Methods 0.000 claims description 40
- 230000004048 modification Effects 0.000 claims description 40
- 238000001556 precipitation Methods 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 15
- 230000003544 deproteinization Effects 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- 229920004890 Triton X-100 Polymers 0.000 claims description 8
- 239000013504 Triton X-100 Substances 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 239000001117 sulphuric acid Substances 0.000 claims description 7
- 235000011149 sulphuric acid Nutrition 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000012065 filter cake Substances 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- YAXWOADCWUUUNX-UHFFFAOYSA-N 1,2,2,3-tetramethylpiperidine Chemical compound CC1CCCN(C)C1(C)C YAXWOADCWUUUNX-UHFFFAOYSA-N 0.000 claims description 5
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000005457 ice water Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102000006382 Ribonucleases Human genes 0.000 claims description 3
- 108010083644 Ribonucleases Proteins 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims description 3
- 238000005201 scrubbing Methods 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 230000035484 reaction time Effects 0.000 abstract description 3
- 239000013049 sediment Substances 0.000 abstract 5
- 238000001035 drying Methods 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000005185 salting out Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 56
- 238000004321 preservation Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- -1 carboxylate salt Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
组别 | 动物数(只) | SOD(U/ml) |
正常对照组 | 7 | 246.98± 9.97 |
改性前PG | 7 | 296.25± 39.13* |
改性后PG | 7 | 332.65± 14.10**# |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310301752.7A CN103396496B (zh) | 2013-07-16 | 2013-07-16 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310301752.7A CN103396496B (zh) | 2013-07-16 | 2013-07-16 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103396496A true CN103396496A (zh) | 2013-11-20 |
CN103396496B CN103396496B (zh) | 2015-07-08 |
Family
ID=49560247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310301752.7A Active CN103396496B (zh) | 2013-07-16 | 2013-07-16 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103396496B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981232A (zh) * | 2014-04-18 | 2014-08-13 | 宁波大学 | 一种功能性嗜酸乳杆菌肽聚糖的制备方法及其抗炎活性应用 |
CN111398194A (zh) * | 2020-04-10 | 2020-07-10 | 上海华茂药业有限公司 | 一种用于测定艾考糊精中肽聚糖的方法 |
CN113024678A (zh) * | 2019-12-25 | 2021-06-25 | 南京农业大学 | 一种从乳杆菌中提取肽聚糖的方法 |
CN113068774A (zh) * | 2021-04-23 | 2021-07-06 | 广州市鱼来鱼旺生物科技有限公司 | 一种用于对虾健康养殖的生态型饵料及其制造方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5144626A (zh) * | 1974-10-15 | 1976-04-16 | Dainippon Pharmaceutical Co | |
SU1630830A1 (ru) * | 1987-08-27 | 1991-02-28 | Всесоюзный Научно-Исследовательский Институт Особо Чистых Биопрепаратов | Способ получени иммуностимул тора |
DE102004060319A1 (de) * | 2004-12-15 | 2006-06-22 | Basf Ag | Herstellung und chemische Modifikation bakterieller Zellwände |
CN101085982A (zh) * | 2006-06-11 | 2007-12-12 | 上海创博生态工程有限公司 | 利用乳酸杆菌和酵母菌生产微生物多糖制剂的制备方法 |
CN101715877A (zh) * | 2009-12-14 | 2010-06-02 | 上海恩创生物技术研究所 | 一种利用乳酸杆菌和酵母菌生产功能性微生物制剂的制备方法 |
CN102174613A (zh) * | 2011-01-31 | 2011-09-07 | 温州医学院 | 一种乳杆菌多糖分离纯化的方法 |
CN102876606A (zh) * | 2012-09-25 | 2013-01-16 | 杭州世博生物技术开发研究所有限公司 | 一种高产肽聚糖的工程菌及其应用 |
-
2013
- 2013-07-16 CN CN201310301752.7A patent/CN103396496B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5144626A (zh) * | 1974-10-15 | 1976-04-16 | Dainippon Pharmaceutical Co | |
SU1630830A1 (ru) * | 1987-08-27 | 1991-02-28 | Всесоюзный Научно-Исследовательский Институт Особо Чистых Биопрепаратов | Способ получени иммуностимул тора |
DE102004060319A1 (de) * | 2004-12-15 | 2006-06-22 | Basf Ag | Herstellung und chemische Modifikation bakterieller Zellwände |
CN101085982A (zh) * | 2006-06-11 | 2007-12-12 | 上海创博生态工程有限公司 | 利用乳酸杆菌和酵母菌生产微生物多糖制剂的制备方法 |
CN101715877A (zh) * | 2009-12-14 | 2010-06-02 | 上海恩创生物技术研究所 | 一种利用乳酸杆菌和酵母菌生产功能性微生物制剂的制备方法 |
CN102174613A (zh) * | 2011-01-31 | 2011-09-07 | 温州医学院 | 一种乳杆菌多糖分离纯化的方法 |
CN102876606A (zh) * | 2012-09-25 | 2013-01-16 | 杭州世博生物技术开发研究所有限公司 | 一种高产肽聚糖的工程菌及其应用 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981232A (zh) * | 2014-04-18 | 2014-08-13 | 宁波大学 | 一种功能性嗜酸乳杆菌肽聚糖的制备方法及其抗炎活性应用 |
CN103981232B (zh) * | 2014-04-18 | 2016-08-17 | 宁波大学 | 一种功能性嗜酸乳杆菌肽聚糖的制备方法及其抗炎活性应用 |
CN113024678A (zh) * | 2019-12-25 | 2021-06-25 | 南京农业大学 | 一种从乳杆菌中提取肽聚糖的方法 |
CN111398194A (zh) * | 2020-04-10 | 2020-07-10 | 上海华茂药业有限公司 | 一种用于测定艾考糊精中肽聚糖的方法 |
CN111398194B (zh) * | 2020-04-10 | 2020-11-03 | 上海华茂药业有限公司 | 一种用于测定艾考糊精中肽聚糖的方法 |
CN113068774A (zh) * | 2021-04-23 | 2021-07-06 | 广州市鱼来鱼旺生物科技有限公司 | 一种用于对虾健康养殖的生态型饵料及其制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103396496B (zh) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103396496B (zh) | 一种改性嗜酸乳杆菌肽聚糖的制备方法 | |
Wang et al. | Three-phase partitioning for the direct extraction and separation of bioactive exopolysaccharides from the cultured broth of Phellinus baumii | |
JP2010526055A (ja) | エキソ多糖 | |
WO2021196572A1 (zh) | 富含岩藻糖的胞外多糖及其制备方法和应用 | |
CN103382232A (zh) | 那曲肝素钙的制备及纯化工艺 | |
CN103360505A (zh) | 聚乙二醇-超声微波辅助提取石榴皮多糖的方法 | |
CN106676156A (zh) | 石胆酸酶催化法制备鹅去氧胆酸的方法 | |
WO2010006498A1 (zh) | 还原型辅酶q10的制备方法 | |
CN108003252B (zh) | 一种具有提高抗氧化活性的浒苔多糖羧甲基化修饰产物及其制备方法 | |
CN104403026A (zh) | 从动物肺脏中分离硫酸乙酰肝素的方法 | |
CN102558392A (zh) | 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法 | |
CN102174613A (zh) | 一种乳杆菌多糖分离纯化的方法 | |
CN101570554A (zh) | 一种补锌剂羧甲基壳寡糖锌的制备方法 | |
CN104861080A (zh) | 番石榴中的多糖及其制备方法和用途 | |
CN105622655B (zh) | 一种稀土‑木犀草素‑咪唑三元配合物及其制备方法 | |
CN100345868C (zh) | 一种低分子硫酸皮肤素及其制备方法 | |
Yuan et al. | Glycosidic linkages of fungus polysaccharides influence the anti-inflammatory activity in mice | |
CN114869852A (zh) | 一种提高灵芝多糖粉抗氧化活性的制备方法及保护剂 | |
CN1219784C (zh) | 利用芬顿反应制备甘露糖醛酸寡糖的方法 | |
WO2024152661A1 (zh) | 一种介质阻挡放电等离子体降解的褐藻多糖及其制备方法与应用 | |
CN101157710B (zh) | 补铁剂羧甲基壳寡糖亚铁的制备方法 | |
KR20210040041A (ko) | 염증 치료에서의 만누론 이산 조성물의 용도 | |
CN115120529B (zh) | 一种丹参红花复合多糖及其制备方法和应用 | |
CN1560063A (zh) | N-乙酰氨基葡萄糖甲缩醛的生产方法 | |
CN115819211A (zh) | 一种辅酶q10的分离纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210430 Address after: 430040 workshop No.3, 4th floor, building B10, phase I, block B, Wuhan hi tech medical instrument Park, 818 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan Yiding Tianyang Biotechnology Co.,Ltd. Address before: Room 439, 4 / F, 101, 4-5 / F, building 1, No. 175, Litang Road, Changping District, Beijing 102200 Patentee before: Beijing Gao Hang United Technology Co.,Ltd. Effective date of registration: 20210430 Address after: Room 439, 4 / F, 101, 4-5 / F, building 1, No. 175, Litang Road, Changping District, Beijing 102200 Patentee after: Beijing Gao Hang United Technology Co.,Ltd. Address before: 315211, Fenghua Road, Jiangbei District, Zhejiang, Ningbo 818 Patentee before: Ningbo University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240407 Address after: 430000 No. 04, floor 4, building B10, phase I, Wuhan hi tech medical device Park, No. 818, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: MAINTAIN BIOMEDICAL (WUHAN) Co.,Ltd. Country or region after: China Address before: 430040 workshop No.3, 4th floor, building B10, phase I, block B, Wuhan hi tech medical instrument Park, 818 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan Yiding Tianyang Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |